TYR: Tyrosinase
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
This is a copper-containing oxidase that functions in the formation of pigments such as melanins and other polyphenolic compounds.
- Drugs that act on it: 3
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Monobenzone | Approved | Tyrosinase inhibitor | Inhibitor | — |
| Arbutin | — | Tyrosinase inhibitor | Inhibitor | — |
| Mequinol | — | Tyrosinase inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Oculocutaneous albinism type 1A
- 0.86
- Oculocutaneous albinism type 1B
- 0.82
- Oculocutaneous albinism type 1
- 0.74
- Abnormal skin pigmentation
- 0.68
- Oculocutaneous albinism
- 0.67
- Ocular albinism with congenital sensorineural deafness
- 0.66
- Vitiligo
- 0.61
- Oculocutaneous albinism type 6
- 0.60
- Temperature-sensitive oculocutaneous albinism type 1
- 0.57
- Hair color
- 0.56
- Skin neoplasm
- 0.55
- Skin cancer
- 0.55
Drugs and mechanisms are from ChEMBL CHEMBL1973 (CC BY-SA 3.0). Gene name, function (UniProt P14679, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets